Physician profile
Rama Samoori
NPI 1457445884
$2,090.60
in general payments reported to CMS, 2019-2025
27 companies · $26.94 in 2025
The $26.94 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $742 · 2020: $270 · 2021: $163 · 2022: $325 · 2023: $238 · 2024: $325 · 2025: $26.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $470.76 | 2019-2024 | Tezspire, Farxiga, Airsupra |
| Abbvie INC. | $231.78 | 2021-2024 | Qulipta |
| Lilly USA, LLC | $224.51 | 2019-2024 | Jardiance |
| Novo Nordisk INC | $172.42 | 2019-2024 | Wegovy, Ozempic, Rybelsus |
| Silk Road Medical, INC. | $167.27 | 2022 | |
| Ethicon INC. | $107.27 | 2022 | |
| Allergan, INC. | $80.06 | 2019-2020 | |
| Adlon Therapeutics L.P. | $65.65 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $54.05 | 2019 | |
| Glaxosmithkline, LLC. | $50.13 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.51 | 2019 | |
| Exact Sciences Corporation | $42.08 | 2023-2024 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $41.65 | 2019-2020 | |
| Amgen INC. | $40.70 | 2023-2024 | Otezla, Repatha |
| Edwards Lifesciences Corporation | $31.15 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $28.30 | 2021 | |
| Pfizer INC. | $28.28 | 2019 | |
| Amarin Pharma, INC. | $28.02 | 2019 | |
| Inari Medical, INC. | $27.78 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $26.94 | 2025 | Inceptiv |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.45 | 2019-2020 | |
| Sanofi Pasteur INC. | $25.00 | 2019 | |
| Ibsa Pharma INC. | $23.50 | 2019 | |
| Eisai INC. | $15.25 | 2021 | |
| Antares Pharma, INC. | $15.18 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.25 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rama Samoori listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.